The clinical course of CLL is very heterogeneous, ranging from a fairly asymptomatic sickness that will even regress spontaneously into a progressive condition that ultimately leads to the affected individual’s Demise, so there has usually been outstanding desire in deciding the prognosis of person patients. While several prognostic markers have